Showing 15,461 - 15,480 results of 102,485 for search '(( 50 ((mean decrease) OR (teer decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.52s Refine Results
  1. 15461
  2. 15462
  3. 15463
  4. 15464
  5. 15465

    Therapeutic effects of scFv-hD6-Ec and scFv-h3D6-Pp. by Laia Montoliu-Gaya (4329709)

    Published 2017
    “…<p><b>(A) Viability assays in SH-SY5Y neuroblastoma cell line</b>. …”
  6. 15466
  7. 15467
  8. 15468
  9. 15469

    Small Open Reading Frames, Non-Coding RNAs and Repetitive Elements in <i>Bradyrhizobium japonicum</i> USDA 110 by Julia Hahn (3279486)

    Published 2016
    “…We found that BjsR1 and BjsR3 have homologs outside the genus <i>Bradyrhizobium</i>, and BjsR5, BjsR6, BjsR7, and BjsR10 have up to four imperfect copies in <i>Bradyrhizobium</i> genomes. …”
  10. 15470
  11. 15471
  12. 15472
  13. 15473
  14. 15474

    Evaluating the Potential of Ozone Microbubbles for Inactivation of Tulane Virus, a Human Norovirus Surrogate by Bozhong Guan (18598178)

    Published 2024
    “…After 2, 10, and 20 min postgeneration, the ozone concentration of microbubbles naturally decreased from 4 ppm to 3.2 ± 0.2, 2.26 ± 0.19, and 1.49 ± 0.23 ppm and resulted in 1.43 ± 0.44, 0.88 ± 0.5, and 0.68 ± 0.53 log<sub>10</sub> viral reductions, respectively, while the ozone concentration of aqueous ozone decreased from 4 ppm to 2.52 ± 0.07, 0.43 ± 0.05, and 0.09 ± 0.01 ppm and produced 0.8 ± 0.28, 0.29 ± 0.41, and 0.16 ± 0.21 log<sub>10</sub> reductions against Tulane virus, respectively (<i>p</i> = 0.0526), suggesting that structuring of ozone in the bubbles over the applied treatment conditions did not have a significant effect, though future study with continuous generation of ozone microbubbles is needed.…”
  15. 15475

    A visual summary of the key study findings. by Joachim Worthington (8394213)

    Published 2024
    “…Modelling was used to estimate short- and long-term effects on colorectal cancer incidence and mortality, including ongoing impact of patient backlogs. A hypothetical mitigation strategy was simulated, with diagnostic and treatment capacities increased by 5% from 2022 to address backlogs. …”
  16. 15476
  17. 15477

    Persistent HIV-1 suppression after deferiprone cessation in treatment-naive HIV-infected subjects. by Deepti Saxena (462177)

    Published 2016
    “…<p>Discontinuation trial design (DTD) is used to analyze long-term rebound following HIV-1 RNA—based segregation into aDecrease’ and a ‘No decrease’ cohort, defined by viral load post-drug on Day 7 relative to viral load pre-drug on Day 1. …”
  18. 15478

    Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β. by Paul R. Clark (714064)

    Published 2015
    “…A plot of the percent increase over basal TEER values (measured at the peak of the TNF-induced TEER increase, mean 0.7±0.01 hours; y-axis) vs. basal TEER (reported in ohms and read on a 96W20idf ECIS array; x-axis). …”
  19. 15479

    Table_1_Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients.docx by Zhong-Xiu Wang (9729359)

    Published 2020
    “…Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, P = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, P = 0.019). …”
  20. 15480